Logo (Actavis) 454 (Deferasirox 125 mg)
Pill imprint Logo (Actavis) 454 has been identified as Deferasirox 125 mg.
Deferasirox is used in the treatment of iron overload; thalassemia; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about deferasirox
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: chelating agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.